PHARMCARE 4 (PUBLIC HEALTH): CREATE A RESPONSE against the molecules in the PATHOGEN'S CAPSULE.

In comparison to plain polysaccharide vaccines, they
benefit from a technology that binds the polysaccharide to a carrier protein that can INDUCE A LONG-TERM PROTECTIVE RESPONSE EVEN IN INFANTS.

Question

CRE­A­TE A RESPONSE against the mo­le­cu­les in the PATHOGEN'S  CAPSULE.

In comparison to plain  polysaccharide vaccines, they 
benefit from a tech­no­lo­gy that binds the po­ly­sa­c­cha­ri­de to a  carrier protein that can INDUCE A LONG-TERM PROTECTIVE RESPONSE EVEN IN INFANTS.

LEIGHTON DWIGHT OBILLOS · Accepted Answer

Conjugate subunit vaccines

PHARMCARE 4 (PUBLIC HEALTH)

CRE­A­TE A RESPONSE against the mo­le­cu­les in the PATHOGEN'S CAPSULE. In comparison to plain polysaccharide vaccines, they benefit from a tech­no­lo­gy that binds the po­ly­sa­c­cha­ri­de to a carrier protein that can INDUCE A LONG-TERM PROTECTIVE RESPONSE EVEN IN INFANTS.

Conjugate subunit vaccines

Autor

CREATE A RESPONSE against the molecules in the PATHOGEN'S CAPSULE. In comparison to plain polysaccharide vaccines, they benefit from a technology that binds the polysaccharide to a carrier protein that can INDUCE A LONG-TERM PROTECTIVE RESPONSE EVEN IN INFANTS.